ArticleCancer research and treatment2023

Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy.

Youzhao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.